Clinical trial Recruiting at 1 site Interventional Ages 2 to 13

Testing blood samples for early diagnosis of type 1 diabetes and celiac disease

Official title: Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

Run by Meyer Children's Hospital IRCCS · NCT06849622 · Data updated 2026-11-12

This study is testing if a new way of checking blood samples can help find type 1 diabetes and celiac disease earlier in children.

More Diabetes Mellitus trials

Quick facts

Study typeInterventional
Ages2 Years to 13 Years
SexAll
Enrollment1500 (estimated)
SponsorMeyer Children's Hospital IRCCS
Academic / other
Locations1 site (Florence, Italy)
StatusRecruiting
StartedNovember 4, 2024
Main results expectedMarch 30, 2026
Study endsMarch 30, 2026
Registry record updatedFebruary 27, 2025
Trial IDNCT06849622 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 2-13 years who either have a confirmed diagnosis of type 1 diabetes or celiac disease or are healthy controls without these conditions.

Probably not a fit

Patients outside the age range of 2-13 years or those with other unrelated health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study focuses on the early diagnosis of type 1 diabetes and celiac disease in children by screening for autoantibodies in blood samples. It aims to evaluate the concordance of results obtained from two different methods: dried blood spots on cards and traditional serum samples. The study will also assess the feasibility and acceptability of this screening approach among pediatricians and the local population in Tuscany. By identifying these conditions early, the study seeks to facilitate timely intervention and prevent severe complications.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and treatment of type 1 diabetes and celiac disease in children, potentially reducing the risk of severe health complications.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in early diagnosis of autoimmune conditions through blood screening methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 2-13 years
* Patients with a confirmed diagnosis of type 1 diabetes or celiac disease (positive controls) and children who do not have type 1 diabetes or celiac disease or autoantibodies associated with these pathologies (controls)
* Obtained informed consent

Exclusion Criteria:

* none

Where it's running

  • Meyer Children's Hospital IRCCS
    Florence, Italy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.